{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:57Z","timestamp":1786119417996,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6,19]]},"DOI":"10.1097\/qad.0b013e3283396007","type":"journal-article","created":{"date-parts":[[2010,4,27]],"date-time":"2010-04-27T13:11:10Z","timestamp":1272373870000},"page":"1519-1525","source":"Crossref","is-referenced-by-count":21,"title":["Risk factors for \u2018unmasking immune reconstitution inflammatory syndrome\u2019 presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients"],"prefix":"10.1097","volume":"24","author":[{"given":"Nadia","family":"Valin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Pacanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Denoeud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Lalande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Fonquernie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Marie","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Meynard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R2-14-20210130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R3-14-20210130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/QAD.0b013e32832ec1f4","article-title":"Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Haddow","year":"2010","journal-title":"AIDS"},{"key":"R4-14-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"R5-14-20210130","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R6-14-20210130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0b013e3181594c8c","article-title":"Immune reconstitution inflammatory syndrome: risk factors and treatment implications","volume":"46","author":"Manabe","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-14-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R8-14-20210130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/425742","article-title":"Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy","volume":"39","author":"Breton","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R9-14-20210130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/thx.2003.019224","article-title":"Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection","volume":"59","author":"Breen","year":"2004","journal-title":"Thorax"},{"key":"R10-14-20210130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.aids.0000176221.33237.67","article-title":"Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?","volume":"19","author":"Breen","year":"2005","journal-title":"AIDS"},{"key":"R11-14-20210130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/sti.79.4.337","article-title":"Adult respiratory distress syndrome as a severe immune reconstitution disease following the commencement of highly active antiretroviral therapy","volume":"7","author":"Goldsack","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R12-14-20210130","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAD.0b013e328011981a","article-title":"A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis","volume":"21","author":"Dautremer","year":"2007","journal-title":"AIDS"},{"key":"R13-14-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.200410-1342OC","article-title":"Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan","volume":"172","author":"Seyler","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-14-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/QAD.0b013e32831d2a98","article-title":"Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R15-14-20210130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1086\/595985","article-title":"Unmasking tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy","volume":"199","author":"Manabe","year":"2009","journal-title":"J Infect Dis"},{"key":"R16-14-20210130","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and \u2018unmasking\u2019 of tuberculosis during antiretroviral therapy","volume":"177","author":"Lawn","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-14-20210130","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/630208","article-title":"Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort","volume":"49","author":"Haddow","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R18-14-20210130","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32832d3b6d","article-title":"Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R19-14-20210130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"key":"R20-14-20210130","first-page":"1282","article-title":"Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis","volume":"11","author":"Burman","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"R23-14-20210130","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/QAD.0b013e32832e05c8","article-title":"Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease","volume":"23","author":"Lawn","year":"2009","journal-title":"AIDS"},{"key":"R24-14-20210130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1473-3099(09)70149-5","article-title":"Rapid diagnosis of tuberculosis through the detection of mycobacterial DNA in urine by nucleic acid amplification methods","volume":"8","author":"Green","year":"2009","journal-title":"Lancet Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201006190-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:32Z","timestamp":1786040132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201006190-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,19]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283396007","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,19]]}}}